°³²¼¼ºê¶õ½ºº´¿ø ´ëÇѺ´¸®ÇÐȸ ½ÅÀ庴¸®¿öÅ©¼¥ : 2019-09-21 |
|
°³²¼¼ºê¶õ½ºº´¿ø ´ëÇѺ´¸®ÇÐȸ ½ÅÀ庴¸®¿öÅ©¼¥ : 2019-09-21 ±³À°ÀÏÀÚ : 2019-09-21 ±³À°Àå¼Ò : °³²¼¼ºê¶õ½ºº´¿ø º»°ü ´ë°´ç ±³À°ÁÖÁ¦ : ½ÅÀ庴¸®¿öÅ©¼¥ ÁÖÃÖ±â°ü : ´ëÇѺ´¸®ÇÐȸ ´ã´çÀÚ : ´ëÇѺ´¸®ÇÐȸ ¿¬¶ôó : 02-795-3094 À̸ÞÀÏ : kspjamoon@kams.or.kr ±³À°Á¾·ù : º´¸®°ú Âü¼®¿¹»óÀοø : 150¸í Èñ¸ÁÆòÁ¡ : 5Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ ¼¼ºÎ¼ö°·á : 80,000¿ø ºñ°í »çÀüµî·Ï Àü°øÀÇ 5¸¸¿ø, Àü¹®ÀÇ 7¸¸¿ø ÇöÀåµî·Ï Àü°øÀÇ 6¸¸¿ø, Àü¹®ÀÇ 8¸¸¿ø ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 09-21 º»°ü ´ë°´ç 10:05~10:35 Glomerulonephritis with organized deposit ¼º¼øÈñ(ÀÌÈÀÇ´ë) ±³À°½Ã°£ 09-21 º»°ü ´ë°´ç 10:35~11:05 Renal diseases associated with monoclonal immunoglobulins other than amyloidosis ÇÑÁö¿µ(ÀÎÇÏÀÇ´ë) ±³À°½Ã°£ 09-21 º»°ü ´ë°´ç 11:20~11:50 Diabetic nephropathy ¾ö¹Î¼·(¿¬¼¼¿øÁÖÀÇ´ë) ±³À°½Ã°£ 09-21 º»°ü ´ë°´ç 11:50~12:20 Lupus nephritis and other connective tissue diseases ±è¹Ì¼º(¿ï»êÀÇ´ë) ±³À°½Ã°£ 09-21 º»°ü ´ë°´ç 13:30~14:15 aHUS and thrombotic microangiopathy ¹®°æö,ÀÌÇÏÁ¤(¼¿ïÀÇ´ë) ±³À°½Ã°£ 09-21 º»°ü ´ë°´ç 14:15~14:55 Clinical aspects of renal allograft dysfunction Á¤º´ÇÏ(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 09-21 º»°ü ´ë°´ç 15:10~15:40 Diagnosis of allograft rejection: review ÀÓ¹üÁø(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 09-21 º»°ü ´ë°´ç 15:40~16:20 Banff classification: recent update ±Ç±â¿µ(¼º±Õ°üÀÇ´ë) ±³À°½Ã°£ 09-21 º»°ü ´ë°´ç 16:20~16:50 BK virus nephropathy and other complications of allograft kidney ÇѸ¸ÈÆ(°æºÏÀÇ´ë) |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|